July 24, 2014 7:34 AM ET

Capital Markets

Company Overview of Symphony Capital LLC

Executive Profile

Robert A. Gelfand M.D.

Member of Clinical Advisory Board, Cymabay Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Robert A. Gelfand is a former Group Director of Clinical Development, Head of the Metabolic Diseases Clinical Research Group, and Global Candidate Team Leader for inhaled insulin of Pfizer. Dr. Gelfand is a clinical development expert of diabetes and metabolic diseases. Dr. Gelfand is currently a Member of the Clinical Advisory Council at Symphony Capital LLC. He is also an Associate Clinical Professor of Medicine at Yale. Dr. Gelfand is Board-certified in Internal ...

Corporate Headquarters

875 Third Avenue
New York, New York 10022

United States

Phone: 212-632-5400
Fax: 212-632-5401

Board Members Memberships

There is no Board Members Memberships data available.

Education

Unknown/Other Education 1974
The Leland Stanford Junior University
MD 1978
Yale University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Symphony Capital LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.